Events and Presentations

Elicera participates in a two-day conference in Uppsala on the topic of ATMP where CSO Magnus Essand among other things will hold a company presentation. 

BIO-Europe convenes over 5,500 attendees, representing 60 countries and 2,220+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

Company presentation at 13:45 CET. 

INTERNATIONAL PARTNERING, STRATEGY & INVESTMENT FOR NORDIC LIFE SCIENCE EXECUTIVE LEADERS

Company presentation 14.20-14.55. 

Company presentation at 11.30. 

Largest event held by Erik Penser Bank. Time and place: May, 25, 2023. Place: Haymarket by Scandic in Stockholm Time: Ca 09:00-17:00 CET

Company presentation. 

Company presentation that can be seen on the link below. 

Partnering event. 

Company presentation at 11.45 CET. 

The presentation can be followed live in the link below. 

Our CEO will present Elicera and the iTANK-platform at the CAR-TCR Summit Europe in London. 

Head of translational research at Elicera, Di Yu, to present the iTANK-platform and ELC-201 on December 7 at 9:00 am EDT. 

Company presentation

Company presentation 10:30-11:00. 

Partnering event. 

Elicera is sponsoring this event focusing on engineering strategies to delivering safe and effective adoptive cell therapy products to clinical promise, commercial scale manufacturing and patients. CEO, Jamal El-Mosleh, to present the iTANK-platform on November 2 at 15:55 CET. 

Partner event in Malmö. 

Place: 7A Posthuset, Vasagatan 28 in Stockholm

Elicera is sponsoring this event focusing on engineering strategies to deliver persistent, efficacious, safe cell therapy products. Senior Scientist, Tina Sarén, to present the iTANK-platform on August 22 at 1:50 pm EDT and participate in a panel discussion. 

The Nordic Health Summit Japan is a partnering and investor conference aimed at connecting Nordic healthcare innovations with Japanese investors, industry and ecosystems. We invite innovative Nordic health tech and Life Science companies to explore partnerships with Japanese stakeholders including pharmaceutical companies, investors and medical device companies eager to connect with the Nordics.

Elicera participates in partnering conference. 

SWECARNET, Sweden’s network for clinical use of CAR T-cells, will hold an Educational Day on April 27th, 2022, where Elicera’s CSO, Professor Magnus Essand, will hold a presentation on the topic: What will reseach bring in the future? More information and the program can be found here: https://atmpsweden.se/events/swecarnet-utbildningsdag-2022/ Registration can be done here: https://www.eventbrite.com/e/swecarnet-utbildningsdag-biljetter-265001345157

Elicera participates in partnering conference. 

We will participate at Redeye Theme: Regenerative Medicine / Cell Therapy on 23 February Our CEO presents at 09:30 CET. 

CEO presents at HC Andersen at 11.00 CET. 

See our CEO present the company in the link below:

See the company presentation (in Swedish) in the link below: 

Company presentation 13:00-13:30 CET.

Company presentation at 11:30. See the presentation in the link below. 

Returning for its sixth year, LSX’s Inv€$tival Showcase directly connects life science corporates to global capital and partners. An international showcase of early, growth stage and public life science and health technology companies, Inv€$tival ShowcaseTM provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European life sciences investment. The company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond.

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Nearly 1,300 delegates from 40 countries, including 75% from pharma and biotech organizations, last convened in-person in Lisbon in 2019 to discuss the latest advances in protein and antibody engineering.

DI Yu will present preclinical iTANK-data at an HC Andersen Capital Online event at 11.00 - 11.20. See the presentation below.

Elicera's Chief Development Officer, Dr Di Yu, will orally present preclinical proof-of-concept data for the company's iTANK platform during the upcoming ESGCT Collaborative Virtual Congress to be held on October 19-22, 2021. This is also the first time the iTANK platform will be publicly presented.

HC Andersen Capital holds a virtual life science event with focus on immunotherapy. 

CEO Jamal El-Mosleh holds a company presentation June 7th at 12.00 CET at HC Andersen Capital. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at Biostock's Virtual Investor Pitch, May 31st at 10.00 CET. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at Aktiespararnas event "Aktiedagen Göteborg" on May 17th at 11.30 CET. See the presentation in the link below. 

Elicera participates in LSX World Congress 2021 Virtual, an event for meetings with potential partners and investors. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at "Investerarafton 27 januari" between 12.30-13.00. 

CEO Jamal El-Mosleh holds a company presentation. See the presentation on the link below.